Showing results (731-740 of 963) with videos related to
Sort By:
Pageof 97
Pharmaceutical Research|July 27, 2012
Modeling the yew tree tubulin and a comparison of its interaction with paclitaxel to human tubulinJack A Tuszynski, Travis J A Craddock, Jonathan Y Mane, et al.Hepatology (Baltimore, Md.)|May 1, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first stepJessica Howell, Chris Seaman, Jack Wallace, et al.Gastroenterology|January 28, 2014
Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNAHenry L Y Chan, Chi Kuen Chan, Aric Josun Hui, et al.Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.Journal of Nephrology|December 20, 2023
Impact of COVID-19 on patient experience of kidney care: a rapid reviewLucy Mackintosh, Paula Ormandy, Amanda Busby, et al.Nucleic Acids Research|December 21, 2004
ChickVD: a sequence variation database for the chicken genomeJing Wang, Ximiao He, Jue Ruan, et al.Hepatology (Baltimore, Md.)|May 13, 2017
Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimenEdward J Gane, Mitchell L Shiffman, Kyle Etzkorn, et al.Genomics, Proteomics & Bioinformatics|March 9, 2011
Evolutionary transients in the rice transcriptomeJun Wang, Jianguo Zhang, Ruiqiang Li, et al.Journal of Hepatology|May 24, 2016
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis BAnna S Lok, Calvin Q Pan, Steven-Huy B Han, et al.Hepatology Communications|February 7, 2018
The emergence of NS5B resistance associated substitution S282T after sofosbuvir-based treatmentEdward J Gane, Sophie Metivier, Ronald Nahass, et al.Pageof 97